Qingdao Vland Biotech Co Ltd (603739) - Total Liabilities

Latest as of September 2025: CN¥1.14 Billion CNY ≈ $166.87 Million USD

Based on the latest financial reports, Qingdao Vland Biotech Co Ltd (603739) has total liabilities worth CN¥1.14 Billion CNY (≈ $166.87 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Qingdao Vland Biotech Co Ltd to evaluate the company's liquid asset resilience ratio.

Qingdao Vland Biotech Co Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Qingdao Vland Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Qingdao Vland Biotech Co Ltd's balance sheet.

Qingdao Vland Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Qingdao Vland Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Miller Industries Inc NYSE:MLR	USA	$183.69 Million
AS Tallink Grupp HE:TALLINK	Finland	€600.30 Million
Nueva Expresión Textil S.A. MC:NXT	Spain	€51.93 Million
Stabilus S.A. XETRA:STM	Germany	€1.22 Billion
Apogee Optocom Co Ltd TW:6426	Taiwan	NT$104.48 Million
Altia Consultores S.A. MC:ALC	Spain	€84.38 Million
Djurslands Bank CO:DJUR	Denmark	Dkr15.06 Billion
QUADIENT SA ADR1/15/EO 1 F:NEQ0	Germany	€1.41 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Qingdao Vland Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 603739 equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.08	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.64	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Qingdao Vland Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Qingdao Vland Biotech Co Ltd (2014–2024)

The table below shows the annual total liabilities of Qingdao Vland Biotech Co Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.11 Billion ≈ $162.57 Million	-8.08%
2023-12-31	CN¥1.21 Billion ≈ $176.87 Million	+43.05%
2022-12-31	CN¥844.93 Million ≈ $123.64 Million	+57.59%
2021-12-31	CN¥536.18 Million ≈ $78.46 Million	+59.47%
2020-12-31	CN¥336.22 Million ≈ $49.20 Million	+35.03%
2019-12-31	CN¥248.99 Million ≈ $36.44 Million	-20.69%
2018-12-31	CN¥313.94 Million ≈ $45.94 Million	+7.88%
2017-12-31	CN¥291.02 Million ≈ $42.59 Million	+7.80%
2016-12-31	CN¥269.96 Million ≈ $39.50 Million	-10.69%
2015-12-31	CN¥302.27 Million ≈ $44.23 Million	-8.00%
2014-12-31	CN¥328.53 Million ≈ $48.07 Million	--

About Qingdao Vland Biotech Co Ltd

SHG:603739 China Biotechnology

Market Cap

$453.20 Million

CN¥3.10 Billion CNY

Market Cap Rank

#12872 Global

#3813 in China

Share Price

CN¥12.24

Change (1 day)

-0.16%

52-Week Range

CN¥10.81 - CN¥16.74

All Time High

CN¥58.91